ZFHX2
gene geneOn this page
Also known as KIAA1762KIAA1056ZFH-5
Summary
ZFHX2 (zinc finger homeobox 2, HGNC:20152) is a protein-coding gene on chromosome 14q11.2, encoding Zinc finger homeobox protein 2 (Q9C0A1). Transcriptional regulator that is critical for the regulation of pain perception and processing of noxious stimuli.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in regulation of sensory perception of pain. Located in nucleus. Implicated in Marsili syndrome.
Source: NCBI Gene 85446 — RefSeq curated summary.
At a glance
- Gene–disease (curated): indifference to pain, congenital, autosomal dominant (Limited, GenCC)
- Clinical variants (ClinVar): 20 total
- Phenotypes (HPO): 10
- MANE Select transcript:
NM_033400
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20152 |
| Approved symbol | ZFHX2 |
| Name | zinc finger homeobox 2 |
| Location | 14q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1762, KIAA1056, ZFH-5 |
| Ensembl gene | ENSG00000136367 |
| Ensembl biotype | protein_coding |
| OMIM | 617828 |
| Entrez | 85446 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000412565, ENST00000419474, ENST00000555334, ENST00000606808
RefSeq mRNA: 1 — MANE Select: NM_033400
NM_033400
CCDS: CCDS55907
Canonical transcript exons
ENST00000419474 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001269869 | 23523203 | 23526679 |
| ENSE00001493371 | 23532567 | 23533084 |
| ENSE00001493372 | 23533285 | 23535374 |
| ENSE00001627418 | 23526847 | 23526973 |
| ENSE00001655044 | 23520857 | 23522941 |
| ENSE00001657514 | 23529710 | 23529768 |
| ENSE00001730956 | 23530120 | 23530194 |
| ENSE00001741306 | 23527604 | 23527804 |
| ENSE00001747806 | 23531481 | 23531721 |
| ENSE00002454304 | 23551343 | 23551765 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 93.40.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1746 / max 60.6110, expressed in 834 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 142485 | 1.0367 | 467 |
| 142487 | 0.8675 | 405 |
| 142484 | 0.2353 | 122 |
| 142483 | 0.0268 | 11 |
| 142486 | 0.0083 | 5 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 93.40 | gold quality |
| sperm | CL:0000019 | 83.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.22 | gold quality |
| left testis | UBERON:0004533 | 80.55 | gold quality |
| right testis | UBERON:0004534 | 80.15 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 78.87 | silver quality |
| testis | UBERON:0000473 | 78.83 | gold quality |
| cerebellar vermis | UBERON:0004720 | 78.69 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 77.87 | gold quality |
| sural nerve | UBERON:0015488 | 77.75 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 77.01 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 76.36 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.31 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.30 | gold quality |
| cortical plate | UBERON:0005343 | 76.22 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.88 | gold quality |
| cerebellum | UBERON:0002037 | 75.86 | gold quality |
| primary visual cortex | UBERON:0002436 | 75.81 | gold quality |
| right uterine tube | UBERON:0001302 | 75.36 | gold quality |
| kidney epithelium | UBERON:0004819 | 75.27 | gold quality |
| upper arm skin | UBERON:0004263 | 75.23 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.17 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 74.85 | gold quality |
| occipital lobe | UBERON:0002021 | 74.75 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 74.53 | gold quality |
| adenohypophysis | UBERON:0002196 | 74.07 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.06 | gold quality |
| pituitary gland | UBERON:0000007 | 73.77 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.60 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 73.55 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.54 |
| E-GEOD-109979 | no | 50.92 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| PSEN1 | |
| TFAP2A |
Literature-anchored findings (GeneRIF, showing 1)
- this study demonstrate that a A novel human pain insensitivity disorder caused by a point mutation in ZFHX2. (PMID:29253101)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfhx3a | ENSDARG00000073944 |
| mus_musculus | Zfhx2 | ENSMUSG00000040721 |
| rattus_norvegicus | Zfhx2 | ENSRNOG00000025634 |
| drosophila_melanogaster | zfh2 | FBGN0004607 |
| caenorhabditis_elegans | zfh-2 | WBGENE00022518 |
Paralogs (20): FHL1 (ENSG00000022267), LMO3 (ENSG00000048540), LHX5 (ENSG00000089116), ZFHX4 (ENSG00000091656), LHX2 (ENSG00000106689), LHX6 (ENSG00000106852), LHX3 (ENSG00000107187), LHX4 (ENSG00000121454), LMO2 (ENSG00000135363), LMX1B (ENSG00000136944), ZFHX3 (ENSG00000140836), LMO4 (ENSG00000143013), LHX9 (ENSG00000143355), CRIP3 (ENSG00000146215), LHX8 (ENSG00000162624), LMX1A (ENSG00000162761), LMO1 (ENSG00000166407), CRIP2 (ENSG00000182809), CRIP1 (ENSG00000213145), LHX1 (ENSG00000273706)
Protein
Protein identifiers
Zinc finger homeobox protein 2 — Q9C0A1 (reviewed: Q9C0A1)
Alternative names: Zinc finger homeodomain protein 2
All UniProt accessions (4): A0A2P1H683, C9JSX6, Q9C0A1, G3V3N5
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional regulator that is critical for the regulation of pain perception and processing of noxious stimuli.
Subcellular location. Nucleus.
Disease relevance. Marsili syndrome (MARSIS) [MIM:147430] An autosomal dominant disorder characterized by congenital pain insensitivity. Painless cutaneous thermal burns and bone fractures are present in affected individuals. Corneal reflex is absent, sweating is decreased or absent. Patients have normal cognitive abilities, and display no evidence of distal weakness. The disease may be caused by variants affecting the gene represented in this entry.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9C0A1-1 | 1 | yes |
| Q9C0A1-2 | 2 |
RefSeq proteins (1): NP_207646* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR003604 | Matrin/U1-like-C_Znf_C2H2 | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051968 | ZnFinger_Homeobox_TR | Family |
Pfam: PF00046, PF24056
UniProt features (58 total): compositionally biased region 20, region of interest 17, zinc finger region 12, DNA-binding region 3, splice variant 2, sequence conflict 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9C0A1-F1 | 47.92 | 0.06 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 123 (showing top):
GOBP_BEHAVIOR, GOBP_ADULT_BEHAVIOR, GOBP_NEUROGENESIS, ACTGCAG_MIR173P, GOBP_SENSORY_PERCEPTION_OF_PAIN, GOBP_REGULATION_OF_NEURON_DIFFERENTIATION, MODULE_285, MODULE_301, MODULE_99, GOBP_REGULATION_OF_SENSORY_PERCEPTION, GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS, GOBP_REGULATION_OF_SYSTEM_PROCESS, GOBP_SENSORY_PERCEPTION, MODULE_188, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (5): regulation of transcription by RNA polymerase II (GO:0006357), adult behavior (GO:0030534), regulation of neuron differentiation (GO:0045664), regulation of sensory perception of pain (GO:0051930), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), nucleic acid binding (GO:0003676), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| behavior | 1 |
| neuron differentiation | 1 |
| regulation of cell differentiation | 1 |
| sensory perception of pain | 1 |
| regulation of sensory perception | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFHX2 | INPP5K | Q9BT40 | 424 |
| ZFHX2 | TSHZ2 | Q9NRE2 | 423 |
| ZFHX2 | TSHZ3 | Q63HK5 | 418 |
| ZFHX2 | LGALS4 | P56470 | 417 |
| ZFHX2 | RPH3AL | Q9UNE2 | 412 |
| ZFHX2 | EXOSC9 | Q06265 | 408 |
| ZFHX2 | OPRM1 | P35372 | 398 |
| ZFHX2 | TSHZ1 | Q6ZSZ6 | 396 |
| ZFHX2 | MYB | P10242 | 393 |
| ZFHX2 | ZBTB8A | Q96BR9 | 372 |
| ZFHX2 | PRDM12 | Q9H4Q4 | 368 |
| ZFHX2 | POU2F2 | P09086 | 361 |
| ZFHX2 | RERE | Q9P2R6 | 356 |
| ZFHX2 | ZBTB26 | Q9HCK0 | 353 |
| ZFHX2 | ZNF777 | Q9ULD5 | 351 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZFHX2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GPR37 | ZFHX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | ZFHX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAPT | ZFHX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFHX2 | MAPT | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFHX2 | PMP22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PTK2B | ARHGAP10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (25): ZFHX2 (Affinity Capture-RNA), ZFHX2 (Two-hybrid), ADAMTSL4 (Two-hybrid), CYSRT1 (Two-hybrid), KRTAP3-1 (Two-hybrid), ZFHX2 (Affinity Capture-MS), ZFHX2 (Proximity Label-MS), KIF5B (Cross-Linking-MS (XL-MS)), ZFHX2 (Affinity Capture-MS), ZFHX2 (Proximity Label-MS), ZFHX2 (Proximity Label-MS), ZFHX2 (Proximity Label-MS), ZFHX2 (Proximity Label-MS), ZFHX2 (Proximity Label-MS), ZFHX2 (Proximity Label-MS)
ESM2 similar proteins: A2A5E6, A5PK23, A6NKF2, A6PWV5, B0K011, E9Q6W4, O02786, O95402, P09086, P13297, P55198, Q00196, Q08DS3, Q0VDQ9, Q29013, Q2NKI2, Q2VL80, Q2VL82, Q2VL83, Q2VL85, Q2VL86, Q569K4, Q5XI28, Q62255, Q66K41, Q6AXX3, Q6PBT9, Q86V15, Q8BXJ8, Q8IVH2, Q8K4J6, Q8TAX0, Q8VD12, Q8VDL9, Q8WUU4, Q92766, Q969V6, Q96PM9, Q9BXA9, Q9BZE0
Diamond homologs: A0A1L8FFY5, A0A1W2PPF3, A0JNI8, A1L0Z1, A1L2U9, A2PZF9, B0XS89, B1WAZ8, B1WBU4, G5EBU4, G5EC36, G5EE86, G5EEA1, O60315, O62836, O73590, P08048, P09088, P10925, P17010, P17012, P20154, P20662, P20912, P28166, P29674, P31362, P31363, P34764, P34765, P36197, P36198, P36200, P37137, P37275, P42571, P48742, P49335, P50458, P52739
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
20 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 7 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1878 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:23522941:CCTAG:C | acceptor_loss | 1.0000 |
| 14:23526675:GCCTT:G | acceptor_gain | 1.0000 |
| 14:23526676:CCTTC:C | acceptor_gain | 1.0000 |
| 14:23526677:CTT:C | acceptor_gain | 1.0000 |
| 14:23526678:TT:T | acceptor_gain | 1.0000 |
| 14:23526680:C:CC | acceptor_gain | 1.0000 |
| 14:23527602:A:AC | donor_gain | 1.0000 |
| 14:23527603:C:CC | donor_gain | 1.0000 |
| 14:23527603:CTA:C | donor_gain | 1.0000 |
| 14:23522937:CGGGC:C | acceptor_gain | 0.9900 |
| 14:23522942:C:CC | acceptor_gain | 0.9900 |
| 14:23522950:G:C | acceptor_gain | 0.9900 |
| 14:23526676:CCTT:C | acceptor_loss | 0.9900 |
| 14:23526677:CTTCT:C | acceptor_gain | 0.9900 |
| 14:23526678:TTCTA:T | acceptor_loss | 0.9900 |
| 14:23526679:TCTAG:T | acceptor_loss | 0.9900 |
| 14:23526680:C:CG | acceptor_loss | 0.9900 |
| 14:23526681:T:A | acceptor_loss | 0.9900 |
| 14:23526842:CTTAC:C | donor_loss | 0.9900 |
| 14:23526844:TA:T | donor_loss | 0.9900 |
| 14:23526845:AC:A | donor_loss | 0.9900 |
| 14:23526846:C:A | donor_loss | 0.9900 |
| 14:23526846:CCTG:C | donor_gain | 0.9900 |
| 14:23526974:C:CA | acceptor_loss | 0.9900 |
| 14:23527600:TCAC:T | donor_gain | 0.9900 |
| 14:23529689:C:A | donor_gain | 0.9900 |
| 14:23529769:C:CC | acceptor_gain | 0.9900 |
| 14:23530111:AAAAC:A | donor_loss | 0.9900 |
| 14:23530112:AAACT:A | donor_loss | 0.9900 |
| 14:23530113:AACTC:A | donor_loss | 0.9900 |
AlphaMissense
16584 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:23523421:A:G | L2174P | 1.000 |
| 14:23523596:C:G | A2116P | 1.000 |
| 14:23523597:A:C | N2115K | 1.000 |
| 14:23523597:A:T | N2115K | 1.000 |
| 14:23523599:T:C | N2115D | 1.000 |
| 14:23523603:G:C | F2113L | 1.000 |
| 14:23523603:G:T | F2113L | 1.000 |
| 14:23523604:A:G | F2113S | 1.000 |
| 14:23523605:A:G | F2113L | 1.000 |
| 14:23523606:C:A | W2112C | 1.000 |
| 14:23523606:C:G | W2112C | 1.000 |
| 14:23523608:A:G | W2112R | 1.000 |
| 14:23523608:A:T | W2112R | 1.000 |
| 14:23523610:A:T | V2111D | 1.000 |
| 14:23523619:A:T | V2108D | 1.000 |
| 14:23523631:A:G | L2104P | 1.000 |
| 14:23523646:C:A | G2099V | 1.000 |
| 14:23523646:C:T | G2099E | 1.000 |
| 14:23523647:C:G | G2099R | 1.000 |
| 14:23523647:C:T | G2099R | 1.000 |
| 14:23523657:A:C | C2095W | 1.000 |
| 14:23523659:A:G | C2095R | 1.000 |
| 14:23523673:G:T | P2090H | 1.000 |
| 14:23523695:A:G | C2083R | 1.000 |
| 14:23523712:A:G | L2077P | 1.000 |
| 14:23523727:A:G | M2072T | 1.000 |
| 14:23523736:C:A | R2069M | 1.000 |
| 14:23524221:A:C | N1907K | 1.000 |
| 14:23524221:A:T | N1907K | 1.000 |
| 14:23524222:T:A | N1907I | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000070652 (14:23521059 A>G), RS1000308389 (14:23526376 C>T), RS1000375875 (14:23550211 T>C), RS1000420254 (14:23520965 T>C), RS1000476809 (14:23550969 C>T), RS1000481365 (14:23532123 C>T), RS1000546550 (14:23524446 C>T), RS1000577393 (14:23556646 A>G,T), RS1000718292 (14:23530530 G>A), RS1000813340 (14:23530774 T>C), RS1000917911 (14:23524768 A>C), RS1000924271 (14:23545325 T>G), RS1000960209 (14:23537277 C>T), RS1001047550 (14:23539109 C>T), RS1001051872 (14:23550676 G>A)
Disease associations
OMIM: gene MIM:617828 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| indifference to pain, congenital, autosomal dominant | Limited | Autosomal dominant |
Mondo (1): (MONDO:0007828)
Orphanet (0):
HPO phenotypes
10 total (10 of 10 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000559 | Corneal scarring |
| HP:0000632 | Lacrimation abnormality |
| HP:0000966 | Hypohidrosis |
| HP:0001954 | Recurrent fever |
| HP:0002315 | Headache |
| HP:0002661 | Painless fractures due to injury |
| HP:0007021 | Pain insensitivity |
| HP:0008000 | Decreased corneal reflex |
| HP:0010829 | Impaired temperature sensation |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| propionaldehyde | increases methylation | 1 |
| nonanal | increases methylation | 1 |
| n-hexanal | increases methylation | 1 |
| butyraldehyde | increases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| butylbenzyl phthalate | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| caprylic aldehyde | increases methylation | 1 |
| pentanal | increases methylation | 1 |
| heptanal | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV94 | HEK293 eGFP-ZFHX2 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: congenital insensitivity to pain syndrome, Marsili type